Cementos Bio Bio S.A. (SNSE: CEMENTOS)

Cementos Bio Bio Income Statement

Financials in millions CLP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	360,652	348,984	334,004	289,468	242,586	268,614
Revenue Growth (YoY)	3.19%	4.49%	15.39%	19.33%	-9.69%	2.30%
Cost of Revenue	220,913	219,384	228,479	186,287	146,484	158,919
Gross Profit	139,740	129,600	105,525	103,181	96,102	109,694
Selling, General & Admin	97,075	94,713	94,110	86,095	73,039	89,738
Operating Expenses	97,075	94,713	94,110	86,095	73,039	89,738
Operating Income	42,665	34,887	11,415	17,086	23,062	19,957
Interest Expense	-12,654	-14,353	-11,141	-3,561	-4,038	-5,965
Interest & Investment Income	571.8	1,210	1,063	598.99	285.22	923.36
Currency Exchange Gain (Loss)	2,628	434.34	-1,311	1,425	-1,248	-3.51
Other Non Operating Income (Expenses)	6,974	3,574	1,954	2,114	385.14	727.79
EBT Excluding Unusual Items	40,185	25,752	1,980	17,662	18,447	15,639
Gain (Loss) on Sale of Assets	466.61	556.51	3,427	8,655	1,178	745.46
Asset Writedown	-985.44	-584.07	-2,550	-988.27	-3,478	-3,404
Other Unusual Items	-	-	-	685.41	43.04	2,063
Pretax Income	40,562	26,622	5,635	33,911	16,263	15,044
Income Tax Expense	7,689	3,812	-4,926	6,885	2,351	2,095
Earnings From Continuing Operations	32,873	22,809	10,561	27,026	13,912	12,949
Minority Interest in Earnings	28.63	-12.25	-1.13	-146.9	-149.47	155.2
Net Income	32,901	22,797	10,560	26,879	13,763	13,104
Net Income to Common	32,901	22,797	10,560	26,879	13,763	13,104
Net Income Growth	104.56%	115.88%	-60.71%	95.30%	5.03%	-33.73%
Shares Outstanding (Basic)	265	264	264	264	264	264
Shares Outstanding (Diluted)	265	264	264	264	264	264
Shares Change (YoY)	0.17%	-	-	-	-	-
EPS (Basic)	124.31	86.28	39.97	101.73	52.09	49.59
EPS (Diluted)	124.31	86.28	39.97	101.73	52.09	49.59
EPS Growth	104.21%	115.88%	-60.71%	95.30%	5.03%	-33.73%
Free Cash Flow	33,846	23,291	9,374	3,860	24,226	17,780
Free Cash Flow Per Share	127.87	88.15	35.48	14.61	91.69	67.29
Dividend Per Share	23.000	36.000	12.000	48.000	42.000	16.000
Dividend Growth	-8.00%	200.00%	-75.00%	14.29%	162.50%	-56.76%
Gross Margin	38.75%	37.14%	31.59%	35.64%	39.62%	40.84%
Operating Margin	11.83%	10.00%	3.42%	5.90%	9.51%	7.43%
Profit Margin	9.12%	6.53%	3.16%	9.29%	5.67%	4.88%
Free Cash Flow Margin	9.38%	6.67%	2.81%	1.33%	9.99%	6.62%
EBITDA	53,502	48,082	24,159	30,270	34,832	30,633
EBITDA Margin	14.83%	13.78%	7.23%	10.46%	14.36%	11.40%
D&A For EBITDA	10,837	13,195	12,744	13,184	11,770	10,676
EBIT	42,665	34,887	11,415	17,086	23,062	19,957
EBIT Margin	11.83%	10.00%	3.42%	5.90%	9.51%	7.43%
Effective Tax Rate	18.96%	14.32%	-	20.30%	14.45%	13.93%

Source: S&P Capital IQ. Standard template. Financial Sources.